HIV infection continues to spread rapidly via heterosexual transmission, as well as by vertical transmission from mother to newborn child. There is an urgent need to develop appropriate mucosal immunization strategies which have the potential to decrease the rate of acquisition through heterosexual and vertical transmission.
The aim of this collaborative group is to define effective mucosal vaccine strategies for induction of protective anti-HIV envelope secretory IgA on rectal and female genital mucosal surfaces. Preliminary data in mice and primates have demonstrated that optimal mucosal immune responses in the rectum and cervix are produced through site-specific mucosal immunization. It is critical that similar studies be carried out among HIV- and HIV+ women including HIV+ women with high and lower CD4 counts. The oral recombinant cholera B subunit-killed whole cell vaccine has proven to be immunogenic and safe in studies in volunteers in North American and Europe, and does not pose a significant risk to HIV-infected women. The purpose of Project 2 is to investigate possible strategies to mucosal antigen (cholera toxin subunit B) and to HIV-1-envelope related antigens in humans and nonhuman primates.
The Specific Aims of this project are: 1) to investigate optimal immunization strategies utilizing oral, rectal and vaginal routes to induce specific secretory IgA in rectal and cervical mucosa in primates and in HIV+ and HIV- women, using cholera toxin B subunit as a model mucosal antigen; 2) to define optimal mucosal delivery and adjuvant systems for HIV recombinant gp120/160 antigens, utilizing subhuman primates and mucosal immunizations: 3) to evaluate the most promising mucosally-targeted HIV or HIV-CTS combination vaccine in HIV+ and HIV- women, for induction of specific secretory IgA on cervical and rectal mucosal surfaces.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI035543-02
Application #
2071286
Study Section
Special Emphasis Panel (SRC (82))
Project Start
1993-11-01
Project End
1997-10-31
Budget Start
1994-11-01
Budget End
1995-10-31
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Miriam Hospital
Department
Type
DUNS #
039318308
City
Providence
State
RI
Country
United States
Zip Code
02906
Kozlowski, Pamela A; Williams, Selvi B; Lynch, Rebecca M et al. (2002) Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. J Immunol 169:566-74
Kozlowski, P A; Lynch, R M; Patterson, R R et al. (2000) Modified wick method using Weck-Cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody. J Acquir Immune Defic Syndr 24:297-309
Kozlowski, P A; Cu-Uvin, S; Neutra, M R et al. (1999) Mucosal vaccination strategies for women. J Infect Dis 179 Suppl 3:S493-8
Eriksson, K; Quiding-Jarbrink, M; Osek, J et al. (1999) Anatomic segmentation of the intestinal immune response in nonhuman primates: differential distribution of B cells after oral and rectal immunizations to sites defined by their source of vascularization. Infect Immun 67:6210-2
Johansson, E L; Rask, C; Fredriksson, M et al. (1998) Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates. Infect Immun 66:514-20
Kozlowski, P A; Cu-Uvin, S; Neutra, M R et al. (1997) Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun 65:1387-94
Quesnel, A; Cu-Uvin, S; Murphy, D et al. (1997) Comparative analysis of methods for collection and measurement of immunoglobulins in cervical and vaginal secretions of women. J Immunol Methods 202:153-61
Bergquist, C; Johansson, E L; Lagergard, T et al. (1997) Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun 65:2676-84
Furuta, Y; Eriksson, K; Svennerholm, B et al. (1994) Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. Proc Natl Acad Sci U S A 91:12559-63